Alterity Therapeutics Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Alterity Therapeutics stock has a consensus rating of "Buy" and an average price target of $11. The average 1-year stock price forecast is 124.95% higher than the current stock price, while the lowest is $10 (+104.50%) and the highest is $12 (+145.40%).

Price Target: $11 (+124.95%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$11	$11	$12
Change	+104.50%	+124.95%	+124.95%	+145.40%

Analyst Ratings

The average analyst rating for Alterity Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	1	0	1	0	0	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	1	2	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debanjana Chatterjee JonesTrading	JonesTrading	Buy Maintains $16	Buy	Maintains	$16	+227.20%	Jun 29, 2026
Caroline Palomeque Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Initiates $10	Buy	Initiates	$10	+104.50%	Jun 16, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Reiterates $12	Buy	Reiterates	$12	+145.40%	Jun 10, 2026

Financial Forecast

Revenue This Year

3.53M

from 5.44M

-35.11%

from 5.44M

Revenue Next Year

1.65M

from 3.53M

-53.27%

from 3.53M

EPS This Year

-2.58

from -

EPS Next Year

-2.58

from -2.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	4.34M	5.12M	3.92M	4.02M	5.44M	3.53M
Revenue Growth	-	18.06%	-23.56%	2.63%	35.32%	-35.11%
Gross Profit	3.98M	4.76M	3.63M	3.80M	5.31M	3.18M
Gross Margin	91.70%	92.88%	92.72%	94.67%	97.66%	90.00%
Operating Income	-15.18M	-15.50M	-14.64M	-19.61M	-14.66M	-15.79M
Net Income	-15.31M	-12.85M	-13.81M	-19.12M	-12.15M	-13.85M
EPS	-	-	-	-	-	-2.58
Free Cash Flow	-11.91M	-6.46M	-14.53M	-5.36M	-8.66M	-10.77M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	5.8M
Avg	3.5M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.4%
Avg	-35.1%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-2.58
Low	-5.15

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-